Kennedy-Linked FDA Panel Clears Path for Peptide Manufacturing Amid Data Gaps
TL;DR Summary
An FDA advisory panel voted to lift manufacturing restrictions on four peptides for human use despite limited safety and efficacy data, a move critics say was influenced by RFK Jr. and his allies; the FDA could still reject or adopt the panel's recommendation.
- RFK Jr.'s hand-picked committee approves manufacture of peptides he uses Ars Technica
- What to Know About Peptides the FDA Is Considering for Use The New York Times
- America Is About to Go Over a Peptide Cliff The Atlantic
- RFK Jr. promised to stop the ‘aggressive suppression’ of these controversial drugs. He’s making progress. Politico
- FDA considers widening access to peptides promoted by wellness influencers PBS
Reading Insights
Total Reads
1
Unique Readers
5
Time Saved
4 min
vs 5 min read
Condensed
95%
877 → 43 words
Want the full story? Read the original article
Read on Ars Technica